申请人:Boehringer Ingelheim (Canada) Ltd.
公开号:US06242439B1
公开(公告)日:2001-06-05
A compound of formula I
wherein R1 is hydrogen, methyl, ethyl, methoxy or methylthio; R2 and R3 each independently is hydrogen or lower alkyl; R4 is hydrogen, lower alkyl, methoxy, ethoxy or benzyloxy; R5 is lower alkyl, lower cycloalkyl, (CH2)mC(O)OR6 wherein m is the integer 1 or 2 and R6 is lower alkyl, phenyl optionally substituted; optionally Het or Het(lower alkyl); or R4 and R5 together with the nitrogen atom to which they are attached form a nitrogen containing ring optionally substituted with C(O)O-benzyl or with phenyl optionally substituted with C(O)OR7 wherein R7 is lower alkyl or (lower alkyl)phenyl; and Z is lower alkyl or optionally substituted phenyl or Het; with the proviso that when Z is (CH2)p-(Het), then R2 and R3 each is hydrogen; or a therapeutically acceptable acid addition salt thereof which compound is useful in the treatment of HCMV infections.
式I的化合物中,其中R1为氢、甲基、乙基、甲氧基或甲硫基;R2和R3各自独立地为氢或较低的烷基;R4为氢、较低的烷基、甲氧基、乙氧基或苄氧基;R5为较低的烷基、较低的环烷基、(CH2)mC(O)OR6,其中m是整数1或2,R6为较低的烷基、苯基可选择地取代;可选择地为Het或Het(较低的烷基);或者R4和R5与它们连接的氮原子一起形成一个含氮环,该环可选择地取代为C(O)O-苄基或苯基,该苯基可选择地取代为C(O)OR7,其中R7为较低的烷基或(较低的烷基)苯基;Z为较低的烷基或可选择地取代的苯基或Het;但是当Z为(CH2)p-(Het)时,那么R2和R3各自为氢;或其治疗上可接受的酸盐,该化合物在HCMV感染的治疗中有用。